Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to TARGETED THERAPIES

Clinical Advances in Hematology & Oncology

The Development of Menin Inhibitors in AML and ALL

Hematology/Oncology May 20th 2024

Oncology News Central (ONC)

Trastuzumab Deruxtecan Granted Accelerated Approval for HER2-Positive Solid Tumors

Oncology, Medical May 13th 2024

Oncology News Central (ONC)

Nuclear Medicine Is Big Pharma’s New Target in Cancer Race

Oncology, Medical May 13th 2024

The New England Journal of Medicine

Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer

Oncology, Medical April 15th 2024

Oncology News Central (ONC)

FDA Approves Mirvetuximab Soravtansine for FRα-positive, Platinum-Resistant Ovarian Cancer

Oncology, Medical April 1st 2024

The New England Journal of Medicine

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

Hematology/Oncology April 1st 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form